Highlights on Important Medicinal Plants for the Menopause Syndrome

Rafaele   de A.   Rodrigues; Aline       de S. Ramos; José    Luiz P.    Ferreira; Jefferson    Rocha    de A. Silva; Ana    Clara B.    Maria; Maíra    Martins H.    de Almeida; Ana    Claudia F.    Amaral

Abstract

Background: A reduction in ovarian hormones, which is distinctive of menopause, often involves signs and symptoms that compromise the quality of life and health of women. The transient manifestations are changes in the menstrual cycle, vasomotor symptoms, neuropsychological symptoms, and genitourinary changes. In some cases, the hormonal changes can evolve to nontransitory manifestations, which include urinary incontinence, changes in metabolism, osteoporosis, and cardiovascular diseases. Hormone replacement therapy is the treatment of choice to alleviate transient symptoms of menopause; however, there are many limitations, contraindications, and situations in which the risks of adverse effects are high, such as coronary artery disease, stroke, venous thromboembolism, dementia, type 2 diabetes, and the increased incidence of breast cancer.

Objectives: This work aims to highlight important medicinal plants for the treatment of the transient symptoms of menopause, with less side effects than traditional hormone replacement therapy.

Conclusion: There is sufficient information regarding the efficacy and safety for the use of the following plant species in the treatment of transient symptoms of menopause: Actaea racemosa, Glycine max, Trifolium pratense, Salvia officinalis, Humulus lupulus, Panax ginseng, Vitex agnus-- castus, and Trigonella foenum-graecum. Additionally, the search indicated the chemical classes related to the benefits of the selected species, adverse effects, and interactions with other drugs.

Keywords: Climacteric, medicinal herbs, hormone therapy, phytoestrogen, phytotherapy, flavonoid, triterpene, steroids

Graphical Abstract

[1] 
NICE. Menopause: Diagnosis and management [NG23] 2019.https://www.nice.org.uk/guidance/ng23
[2] 
Brazil. Manual de atenção a mulher no climatério/menopausa. Série A [Normas e Manuais Técnicos] Série Direitos Sexuais e Direitos Reprodutivos – Caderno (9) 2008.http://bvsms.saude.gov.br/bvs/publicacoes/manual_atencao_mulher_climaterio.pdf
[3] 
Potter B, Schrager S, Dalby J, Torell E, Hampton A. Menopause. Prim Care  2018; 45(4): 625-41.
[http://dx.doi.org/10.1016/j.pop.2018.08.001] [PMID: 30401346] 
[4] 
Kronenberg F. Hot flashes: epidemiology and physiology. Ann N Y Acad Sci  1990; 592: 52-86.
[http://dx.doi.org/10.1111/j.1749-6632.1990.tb30316.x] [PMID: 2197954] 
[5] 
Huang AJ, Grady D, Jacoby VL, Blackwell TL, Bauer DC, Sawaya GF. Persistent hot flushes in older postmenopausal women. Arch Intern Med  2008; 168(8): 840-6.
[http://dx.doi.org/10.1001/archinte.168.8.840] [PMID: 18443259] 
[6] 
Schneider HPG, Heinemann LAJ, Rosemeier H-P, Potthoff P, Behre HM. The Menopause Rating Scale (MRS): comparison with Kupperman index and quality-of-life scale SF-36. Climacteric  2000; 3(1): 50-8.
[http://dx.doi.org/10.3109/13697130009167599] [PMID: 11910610] 
[7] 
Sydora BC, Fast H, Campbell S, Yuksel N, Lewis JE, Ross S. Use of the Menopause-Specific Quality of Life (MENQOL) questionnaire in research and clinical practice: a comprehensive scoping review. Menopause  2016; 23(9): 1038-51.
[http://dx.doi.org/10.1097/GME.0000000000000636] [PMID: 27300115] 
[8] 
Travers C, O’Neill SM, King R, Battistutta D, Khoo SK. Greene Climacteric Scale: norms in an Australian population in relation to age and menopausal status. Climacteric  2005; 8(1): 56-62.
[http://dx.doi.org/10.1080/13697130400013443] [PMID: 15804732] 
[9] 
Pinkerton JV, Sánchez Aguirre F, Blake J, et al. The NAMS 2017 hormone therapy position statement advisory panel. The 2017 hormone therapy position statement of The North American Menopause Society. Menopause  2017; 24(7): 728-53.
[http://dx.doi.org/10.1097/GME.0000000000000921] [PMID: 28650869] 
[10] 
Pardini D. Hormone replacement therapy in menopause. Arq Bras Endocrinol Metabol  2014; 58(2): 172-81.
[http://dx.doi.org/10.1590/0004-2730000003044] [PMID: 24830594] 
[11] 
Locklear TD, Doyle BJ, Perez AL, Wicks SM, Mahady GB. Menopause in Latin America: Symptoms, attitudes, treatments and future directions in Costa Rica. Maturitas  2017; 104: 84-9.
[http://dx.doi.org/10.1016/j.maturitas.2017.07.008] [PMID: 28923180] 
[12] 
Watkins E. Menopause: The best chapter of our lives. Physician Assist  2018; 3(3): 373-83.
[http://dx.doi.org/10.1016/j.cpha.2018.02.006] 
[13] 
WHO. WHO traditional medicine strategy: 2014-2023 2013.
[14] 
Sousa IMC, Tesser CD. Medicina Tradicional e Complementar no Brasil: inserção no Sistema Único de Saúde e integração com a atenção primária. Cad Saude Publica  2017; 33(1): 8.
[http://dx.doi.org/10.1590/0102-311x00150215] [PMID: 28125126] 
[15] 
Bibliographic database and search site http://www.scopus.com
[16] 
Bibliographic database and search site http://scifinder.cas.org/
[17] 
PubMed, National Center for Biotechnology Information (NCBI); US National Library of Medicine, National Institutes of Health. Bibliographic database and search site https://www.ncbi.nlm.nih.gov/pubmed/
[18] 
Nielsen ILF, Williamson G. Review of the factors affecting bioavailability of soy isoflavones in humans. Nutr Cancer  2007; 57(1): 1-10.
[http://dx.doi.org/10.1080/01635580701267677] [PMID: 17516857] 
[19] 
Hairi HA, Shuid AN, Ibrahim NI, Jamal JA, Mohamed N, Mohamed IN. The effects and action mechanisms of phytoestrogens on vasomotor symptoms during menopausal transition: thermoregulatory mechanism. Curr Drug Targets  2019; 20(2): 192-200.
[http://dx.doi.org/10.2174/1389450118666170816123740] [PMID: 28814228] 
[20] 
Patisaul HB, Jefferson W. The pros and cons of phytoestrogens. Front Neuroendocrinol  2010; 31(4): 400-19.
[http://dx.doi.org/10.1016/j.yfrne.2010.03.003] [PMID: 20347861] 
[21] 
Setchell KDR. The history and basic science development of soy isoflavones. Menopause  2017; 24(12): 1338-50.
[http://dx.doi.org/10.1097/GME.0000000000001018] [PMID: 29189602] 
[22] 
Final assessment report on Glycine max (L) Merr, semen – First version EU: European Medicines Agency 2018.https://www.ema.europa.eu/en/medicines/herbal/glycini-semen
[23] 
Anandhi Senthilkumar H, Fata JE, Kennelly EJ. Phytoestrogens: The current state of research emphasizing breast pathophysiology. Phytother Res  2018; 32(9): 1707-19.
[http://dx.doi.org/10.1002/ptr.6115] [PMID: 29876983] 
[24] 
WHO. Flos Trifolii. WHO monographs on selected medicinal plants  2004; 4: 335-52.https://apps.who.int/medicinedocs/en/m/abstract/Js16713e/
[25] 
Mazaro-Costa R, Andersen ML, Hachul H, Tufik S. Medicinal plants as alternative treatments for female sexual dysfunction: utopian vision or possible treatment in climacteric women? J Sex Med  2010; 7(11): 3695-714.
[http://dx.doi.org/10.1111/j.1743-6109.2010.01987.x] [PMID: 20722793] 
[26] 
Shakeri F, Taavoni S, Goushegir A, Haghani H. Effectiveness of red clover in alleviating menopausal symptoms: a 12-week randomized, controlled trial. Climacteric  2015; 18(4): 568-73.
[http://dx.doi.org/10.3109/13697137.2014.999660] [PMID: 25581426] 
[27] 
Terzic MM, Dotlic J, Maricic S, Mihailovic T, Tosic-Race B. Influence of red clover-derived isoflavones on serum lipid profile in postmenopausal women. J Obstet Gynaecol Res  2009; 35(6): 1091-5.
[http://dx.doi.org/10.1111/j.1447-0756.2009.001059.x] [PMID: 20144173] 
[28] 
WHO. Folium Salviae. WHO monographs on medicinal plants commonly used in the Newly Independent States (NIS)  2010; 335-52.https://apps.who.int/medicinedocs/en/m/abstract/Js17534en/
[29] 
Rahte S, Evans R, Eugster PJ, et al. Salvia officinalis for hot flushes: towards determination of mechanism of activity and active principles. Planta Med  2013; 79(9): 753-60.
[http://dx.doi.org/10.1055/s-0032-1328552] [PMID: 23670626] 
[30] 
Khiya Z, Hayani M, Gamar A, et al. Valorization of the Salvia officinalis L. of the Morocco bioactive extracts: phytochemistry, antioxidant and anticorrosive activities. J King Saud Univ Sci  2019; 31: 322-35.
[http://dx.doi.org/10.1016/j.jksus.2018.11.008] 
[31] 
Štulíková K, Karabín M, Nešpor J, Dostálek P. Therapeutic perspectives of 8-prenylnaringenin, a potent phytoestrogen from hops. Molecules  2018; 23(3)
[http://dx.doi.org/10.3390/molecules23030660] [PMID: 29543713] 
[32] 
Heyerick A, Vervarcke S, Depypere H, Bracke M, De Keukeleire D. A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts. Maturitas  2006; 54(2): 164-75.
[http://dx.doi.org/10.1016/j.maturitas.2005.10.005] [PMID: 16321485] 
[33] 
Hamm AK, Manter DK, Kirkwood JS, Wolfe LM, Cox-York K, Weir TL. The effect of hops (Humulus lupulus L.) extract supplementation on weight gain, adiposity and intestinal function in ovariectomized mice. Nutrients  2019; 11(12): 8.
[http://dx.doi.org/10.3390/nu11123004] [PMID: 31817899] 
[34] 
WHO. Fructus Agni Casti. WHO monographs on selected medicinal plants  2004; 4: 9-29.https://apps.who.int/medicinedocs/en/m/abstract/Js16713e/
[35] 
Zahid H, Rizwani GH, Ishaqe S. Phytopharmacological review on Vitex agnus-castus: a potential medicinal plant. Chin Herb Med  2016; 8(1): 24-9.
[http://dx.doi.org/10.1016/S1674-6384(16)60004-7] 
[36] 
WHO. Rhizoma Cimicifugae Racemosae. WHO monographs on selected medicinal plants  2004; 2: 55-65.https://apps.who.int/medicinedocs/en/d/Js4927e/
[37] 
Instituto Sírio-Libanês de Ensino e Pesquisa. Protocolos de atenção básica: Saúde das mulheres Brasilia (BR): Ministério da Saúde 2016.
[38] 
Burdette JE, Liu J, Chen SN, et al. Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor. J Agric Food Chem  2003; 51(19): 5661-70.
[http://dx.doi.org/10.1021/jf034264r] [PMID: 12952416] 
[39] 
WHO. Radix Ginseng. WHO monographs on selected medicinal plants  1999; 1: 168-82.https://apps.who.int/medicinedocs/en/d/Js2200e/
[40] 
Lee HW, Choi J, Lee Y, Kil K-J, Lee MS. Ginseng for managing menopausal womanʼs health. Medicine (Baltimore)  2016; 95(38)
[http://dx.doi.org/10.1097/MD.0000000000004914] [PMID: 27661038] 
[41] 
Cho J, Park W, Lee S, Ahn W, Lee Y. Ginsenoside-Rb1 from Panax ginseng C.A. Meyer activates estrogen receptor-α and -β, independent of ligand binding. J Clin Endocrinol Metab  2004; 89(7): 3510-5.
[http://dx.doi.org/10.1210/jc.2003-031823] [PMID: 15240639] 
[42] 
Park J, Bui PTC, Song H, et al. Ginseng on nuclear hormone receptors. Am J Chin Med  2017; 45(6): 1147-56.
[http://dx.doi.org/10.1142/S0192415X17500628] [PMID: 28830207] 
[43] 
WHO. Semen Trigonellae Foenugraeci. WHO monographs on selected medicinal plants  2007; 3: 338-48.https://apps.who.int/medicinedocs/en/m/abstract/Js14213e/
[44] 
Brogi H, Elbachir H, El Amrani N, Amsaguine S, Radallah D. Fenugreek seeds estrogenic activity in ovariectomized female rats. Curr Issues Pharm Med Sci  2019; 32(3): 138-45.
[http://dx.doi.org/10.2478/cipms-2019-0026] 
[45] 
Shamshad Begum S, Jayalakshmi HK, Vidyavathi HG, et al. A novel extract of fenugreek husk (FenuSMARTTM) alleviates postmenopausal symptoms and helps to establish the hormonal balance: a randomized, double-blind, placebo-controlled study: effect of FenuSMART on postmenopausal discomforts. Phytother Res  2016; 30(11): 1775-84.
[http://dx.doi.org/10.1002/ptr.5680] [PMID: 27406028] 
[46] 
Henneicke-von Zepelin H-H. 60 years of Cimicifuga racemosa medicinal products : Clinical research milestones, current study findings and current development. Wien Med Wochenschr  2017; 167(7-8): 147-59.
[http://dx.doi.org/10.1007/s10354-016-0537-z] [PMID: 28155126] 
[47] 
EMA/HMPC. European Union herbal monograph on Cimicifuga racemosa (L) Nutt, rhizoma 2018.https://www.ema.europa.eu/en/medicines/herbal/cimicifugae-rhizoma
[48] 
Franco DL, Kale S, Lam-Himlin DM, Harrison ME. Black cohosh hepatotoxicity with autoimmune hepatitis presentation. Case Rep Gastroenterol  2017; 11(1): 23-8.
[http://dx.doi.org/10.1159/000452735] [PMID: 28203134] 
[49] 
Guo Y, Yin T, Wang X, et al. Traditional uses, phytochemistry, pharmacology and toxicology of the genus Cimicifuga: A review. J Ethnopharmacol  2017; 209(209): 264-82.
[http://dx.doi.org/10.1016/j.jep.2017.07.040] [PMID: 28826891] 
[50] 
Kristanc L, Kreft S. European medicinal and edible plants associated with subacute and chronic toxicity part I: Plants with carcinogenic, teratogenic and endocrine-disrupting effects. Food Chem Toxicol  2016; 92: 150-64.
[http://dx.doi.org/10.1016/j.fct.2016.04.007] [PMID: 27090581] 
[51] 
Li J, Gödecke T, Chen S-N, et al. In vitro metabolic interactions between black cohosh (Cimicifuga racemosa) and tamoxifen via inhibition of cytochromes P450 2D6 and 3A4. Xenobiotica  2011; 41(12): 1021-30.
[http://dx.doi.org/10.3109/00498254.2011.603385] [PMID: 21827327] 
[52] 
Drewe J, Bucher KA, Zahner C. A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients. Springerplus  2015; 4: 65.
[http://dx.doi.org/10.1186/s40064-015-0808-y] [PMID: 25713759] 
[53] 
Kargozar R, Azizi H, Salari R. A review of effective herbal medicines in controlling menopausal symptoms. Electron Physician  2017; 9(11): 5826-33.
[http://dx.doi.org/10.19082/5826] [PMID: 29403626] 
[54] 
Kanadys W, Baranska A, Jedrych M, Religioni U, Janiszewska M. Effects of red clover (Trifolium pratense) isoflavones on the lipid profile of perimenopausal and postmenopausal women-A systematic review and meta-analysis. Maturitas  2020; 132: 7-16.
[http://dx.doi.org/10.1016/j.maturitas.2019.11.001] [PMID: 31883666] 
[55] 
Ghorbani A, Esmaeilizadeh M. Pharmacological properties of Salvia officinalis and its components. J Tradit Complement Med  2017; 7(4): 433-40.
[http://dx.doi.org/10.1016/j.jtcme.2016.12.014] [PMID: 29034191] 
[56] 
WHO. Strobilus Lupuli. WHO monographs on selected medicinal plants  2007; 3: 236-46.https://apps.who.int/medicinedocs/en/m/abstract/Js14213e/
[57] 
Yuan Y, Qiu X, Nikolić D, et al. Inhibition of human cytochrome P450 enzymes by hops (Humulus lupulus) and hop prenylphenols. Eur J Pharm Sci  2014; 53: 55-61.
[http://dx.doi.org/10.1016/j.ejps.2013.12.003] [PMID: 24342125] 
[58] 
EMA/HMPC. Final community herbal monograph on Panax ginseng CA Meyer, radix 2018.https://www.ema.europa.eu/en/medicines/herbal/ginseng-radix
[59] 
Ghorbani Z, Mirghafourvand M. A meta-analysis of the efficacy of Panax ginseng on menopausal women’s sexual function. Int J Women’s Health Reprod Sci  2019; 7(1): 124-33.
[http://dx.doi.org/10.15296/ijwhr.2019.20] 
[60] 
Ghorbani Z, Mirghafourvand M, Charandabi SM-A, Javadzadeh Y. The effect of ginseng on sexual dysfunction in menopausal women: A double-blind, randomized, controlled trial. Complement Ther Med  2019; 45: 57-64.
[http://dx.doi.org/10.1016/j.ctim.2019.05.015] [PMID: 31331583] 
[61] 
Malati CY, Robertson SM, Hunt JD, et al. Influence of Panax ginseng on cytochrome P450 (CYP)3A and P-glycoprotein (P-gp) activity in healthy participants. J Clin Pharmacol  2012; 52(6): 932-9.
[http://dx.doi.org/10.1177/0091270011407194] [PMID: 21646440] 
[62] 
Mateo-Carrasco H, Gálvez-Contreras MC, Fernández-Ginés FD, Nguyen TV. Elevated liver enzymes resulting from an interaction between Raltegravir and Panax ginseng: a case report and brief review. Drug Metabol Drug Interact  2012; 27(3): 171-5.
[http://dx.doi.org/10.1515/dmdi-2012-0019] [PMID: 23092794] 
[63] 
Ramanathan MR, Penzak SR. Pharmacokinetic Drug Interactions with Panax ginseng. Eur J Drug Metab Pharmacokinet  2017; 42(4): 545-57.
[http://dx.doi.org/10.1007/s13318-016-0387-5] [PMID: 27864798] 
[64] 
Daniele C, Thompson Coon J, Pittler MH, Ernst E. Vitex agnus castus: a systematic review of adverse events. Drug Saf  2005; 28(4): 319-32.
[http://dx.doi.org/10.2165/00002018-200528040-00004] [PMID: 15783241] 
[65] 
Momoeda M, Sasaki H, Tagashira E, Ogishima M, Takano Y, Ochiai K. Efficacy and safety of Vitex agnus-castus extract for treatment of premenstrual syndrome in Japanese patients: a prospective, open-label study. Adv Ther  2014; 31(3): 362-73.
[http://dx.doi.org/10.1007/s12325-014-0106-z] [PMID: 24604699] 
[66] 
EMA/HMPC.. Final European Union herbal monograph on Vitex agnus-castus L, fructus 2018.https://www.ema.europa.eu/en/medicines/herbal/agni-casti-fructus
[67] 
EMA/HMPC. Final community herbal monograph on Trigonella foenumgraecum L, semen 2011.https://www.ema.europa.eu/en/medicines/herbal/trigonellae-foenugraeci-semen
[68] 
Yadav UCS, Baquer NZ. Pharmacological effects of Trigonella foenum-graecum L. in health and disease. Pharm Biol  2014; 52(2): 243-54.
[http://dx.doi.org/10.3109/13880209.2013.826247] [PMID: 24102093] 

Rights & Permissions Print Cite

Call for Papers in Thematic Issues

Submission closes on : 08 September, 2024

RARE CASES IN GYNECOLOGY-OBSTETRICS

With the development of diagnostic and therapeutic techniques (such as ART techniques) and the immersion of new pathologies (such as COVID19), we are witnessing an increase in the incidence of pathologies that were previously described as rare or exceptional. the practitioner sometimes confronts difficult situations in these cases in diagnostic ...read more

Guest Editor(s): Radhouane Achour

Related Books

Female Arousal and Orgasm: Anatomy, Physiology, Behaviour and Evolution

From Taboo to Wellness: The Facts behind Menopause

Article Metrics

34

1

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/1573404817666210223163845	Print ISSN 1573-4048
Publisher Name Bentham Science Publisher	Online ISSN 1875-6581

Current Women`s Health Reviews